Skip to content
Research Article Open access CC BY 4.0

A Novel Stress Indicating RP-HPLC Method Development and Validation for the Simultaneous Estimation of Velpatasvir and Sofosbuvir in Bulk and Its Tablet Dosage Form

D. Chinababu

Journal of Pharmaceutical Research International · pp. 1–10 · Published 28 Mar 2019

10.9734/jpri/2019/v26i230135

Abstract

Aim: The objective of the study was simplest, accurate, precise and robust reversed phase high performance liquid chromatographic (RP-HPLC) method was developed for the estimation of Velpatasvir (VEL) and Sofosbuvir (SOF) in the bulk and its tablet dosage form. Study Design: The Quantitative and Qualitative estimation and designed forced degradation study of Velpatasvir & Sofosbuvir by RP-HPLC. Place and Duration of Study: The study was carried at Santhiram College of Pharmacy and time taken 4 months. Method: The method was attained by used Waters( 5µm, C18 250 x 4.6 mm) column with mobile phase consists of  0.5 mM disodium hydrogen phosphate buffer pH adjusted to 6.5, with Orthophosphoric acid and Methanol in the ratio of 78:22 v/v, a flow rate of 1.0 mL/min and ultraviolet detection at 285 nm. Results: The method was validated as per ICH guidelines with different parameters, the mean retention times of VEL and SOF were found to be 2.8 & 4.7 min respectively. The resolution between VEL and SOF was found to be 10.66. The Correlation coefficients for calibration curves within the detection range of 32.5 - 97.5 and 125 - 375 µg/mL were 0.999 for VEL and SOF respectively. The LOD and LOQ for VEL and SOF were found to be 0.0068-0.029 µg/mL and 0.104-0.342 µg/mL respectively. Conclusion: The results were indicated that the developed method was used for the routine analysis of VEL & SOF combined form in bulk and its commercial formulation. To the best of our knowledge, there was no method of RP-HPLC for the determination of VEL alone or in combination with SOF molecule.

Velpatasvir sofosbuvir HPLC commercial formulations.

Cited by 17

Analytical Methodologies for Anti-Infective Orphan Drugs: A Comprehensive Review of FDA Approvals (2013-2023) Part 2.

Heba E El-Nakib, Shimaa E. Abdel Aziz, Julia Schaletzky · Critical reviews in analytical chemistry · 2025

Environmentally Friendly Analytical Methods for Quantitative Measurement of Sofosbuvir in Pharmaceutical Formulations: Comparison of HPTLC and UV Spectrophotometric Approaches

Kiran Balasaheb Aher, Girija Balasaheb Bhavar, Madhav Ramdas Shelke · Research Journal of Pharmacy and Technology · 2023

Spectrophotometric and spectrodensitometric quantification of a new antiviral combination

Safar M. Alqahtani, M. Alamri, A. Al-Abbas · Jpc-journal of Planar Chromatography-modern Tlc · 2020

Sofosbuvir: A comprehensive profile

· Profiles of Drug Substances, Excipients and Related Methodology · 2025

Showing 8 of 17 known citations — external sources report more than can currently be individually listed.

Article metrics

Real usage data collected on this platform.

5

Page views

0

PDF downloads

0

Outbound clicks

17

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.